<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Amaya Virós et al.|New England Journal of Medicine|2012Cited by 1k
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based ChemotherapyMatthew D. Galsky, Joaquim Bellmunt, Dean F. Bajorin et al.|Journal of Clinical Oncology|2011Cited by 686
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III TrialRobert J. Motzer, Thomas E. Hutson|Journal of Clinical Oncology|2013Cited by 443
A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors.Arkadiusz Z. Dudek, J. L. Mesías Iglesias, Joyce O’Shaughnessy et al.|Journal of Clinical Oncology|2024Cited by 13